EP 2632454 A1 20130904 - HIV INTEGRASE INHIBITORS
Title (en)
HIV INTEGRASE INHIBITORS
Title (de)
HIV-INTEGRASE-HEMMER
Title (fr)
INHIBITEURS D'INTÉGRASE DE VIH
Publication
Application
Priority
- US 40811410 P 20101029
- US 2011057557 W 20111025
Abstract (en)
[origin: WO2012058173A1] Tricyclic compounds of Formula I are inhibitors of HIV integrase and inhibitors of HIV replication: (I), wherein R1A, R1B, R1C, R2A, R2B, R3A, R3B, R4, R5 and R6 are defined herein. The compounds are useful for the prophylaxis or treatment of infection by HIV and the prophylaxis, treatment, or delay in the onset of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.
IPC 8 full level
A61K 31/235 (2006.01); A61K 31/66 (2006.01)
CPC (source: EP)
A61K 31/235 (2013.01); A61K 31/66 (2013.01); A61K 45/06 (2013.01); A61P 31/18 (2017.12)
Citation (search report)
See references of WO 2012058173A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2012058173 A1 20120503; AU 2011320651 A1 20130502; CA 2814703 A1 20120503; EP 2632454 A1 20130904
DOCDB simple family (application)
US 2011057557 W 20111025; AU 2011320651 A 20111025; CA 2814703 A 20111025; EP 11836929 A 20111025